PCORI Archives
VUMC receives $10 million to study childhood obesity interventions in rural and minority communities in Tennessee and Louisiana
Nov. 28, 2023—Vanderbilt researchers are set to begin studying the ideal “dose” of behavioral interventions to treat childhood obesity in rural and minority communities across Tennessee and Louisiana.
VUMC receives $7 million award from PCORI to compare breathing tube sedation
Jul. 18, 2023—Vanderbilt University Medical Center has received a $7 million, five-year funding award from the Patient-Centered Outcomes Research Institute to compare two sedatives used to place breathing tubes in the emergency department or intensive care unit.
VUMC joins group to accelerate implementation of research findings to improve patient outcomes
Mar. 2, 2023—Vanderbilt University Medical Center is part of a select group of health systems nationwide brought together to accelerate the implementation of medical research results that will improve patient outcomes.
Winkfield to direct engagement for national research network
Feb. 2, 2022—Vanderbilt is set to establish an Engagement Coordinating Center for PCORnet, the National Patient-Centered Clinical Research Network.
STAR Clinical Research Network to receive major grant renewal
Oct. 14, 2021—Vanderbilt's STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States.
VUMC is pacesetter for national aspirin study
May. 20, 2021—According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.
Self-care program for acute heart failure patients studied as standard practice
Apr. 15, 2021—Up to 25% of patients with acute heart failure (AHF) face mortality or hospital readmission within one month after being treated in the emergency department (ED).
A cohort for type 2 diabetes studies
Nov. 17, 2020—A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs.
HCQ doesn’t protect health workers from COVID: study
Nov. 5, 2020—Hydroxychloroquine (HCQ) did not significantly reduce the incidence of COVID-19 among health care workers who participated in a national study that included Vanderbilt University Medical Center.
The role of diet in esophageal cancer
May. 4, 2020—New findings suggest that dietary calcium and magnesium affect the risk of esophageal cancer; if confirmed in interventional studies, they could inform dietary modifications to reduce the burden of this cancer.
Study aims to shield health workers from COVID-19 infection
Apr. 2, 2020—VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.
Tool guides decision-making for prostate cancer patients
Mar. 28, 2019—Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.
